Objectives

• To lead the application of sex/gender medicine to highly prevalent metabolic diseases in Spain.
• To lead translational research in reproductive endocrinology and intermediate metabolism.
• To lead the transfer of scientific knowledge to clinical practice in reproductive endocrinology.

Research lines

• Changes in female androgen excess associated with obesity following weight loss.
• Changes in male hypogonadism associated with obesity following weight loss.
• The influence of obesity and gonadal dysfunction on markers of early cardiovascular disease and cardiovascular risk markers.
• Obesity as a cardiovascular risk factor in women and men.
• The influence of treatment for gonadal dysfunction in both sexes (polycystic ovary syndrome or functional hypogonadotropic hypogonadism) on visceral adiposity and metabolic dysfunction.
• Sex dimorphism in cardioautonomic neuropathy in individuals with type 1 diabetes mellitus.